Popular Articles
Cellulite Treatment

Washington Post Interviews Atul Gawande
The Washington Post"s Ezra Klein spoke with surgeon and writer Atul Gawande. Klein writes: "Gawande"s New Yorker article comparing the medical systems of El Paso and McAllen, Tex., has been a definitional piece in the health reform conversation. President [Barack] Obama has repeatedly invoked it. Senators have talked about it. The media have embraced it. I spoke to Gawande this afternoon about the fallout from his article, the problem of revenue-driven medicine, and whether a public plan would make a difference."
generic viagra online
Families Of Spinal Muscular Atrophy Announces Latest Developments On Three SMA Drug Discovery Programs
Families of Spinal Muscular Atrophy has just released details of the latest developments for the Families of SMA funded therapeutic pipeline.
News of the day
Study Identifies Biomarker That Safely Monitors Tumor Response To New Brain Cancer Treatment; Paves The Way To Phase 1 Clinical Trial
A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, reported in the July 1 issue of Clinical Cancer Research, paves the way for a Phase 1 clinical trial expected to begin in late 2009.
Endocrinology

British Scientists Lead The Way In Dementia Research Despite Funding Gap

British scientists are leading the field at the International Conference of Alzheimer"s Disease, in Vienna (ICAD, 11 - 16 July). Researchers, backed by Alzheimer"s Society, are presenting a host of scientific projects from investigating new targets for drug treatments; studying the impact of mild head injuries on your risk of dementia to assessing people with dementia"s fitness to drive. ICAD is the biggest conference of the year looking at cause, cure, care and prevention of dementia. During the conference, Alzheimer"s Society researcher Dr Kidd, from Cardiff University, will present research on developing an immunotherapy against Alzheimer"s disease. Immunotherapy aims to treat diseases by inducing, enhancing, or suppressing an immune response and has been successfully used in cancer treatments. Dementia researchers are now testing various antibodies to see if they will act as potential treatments for dementia. Dr Fowler, from Edinburgh University, is presenting a poster describing work that assesses whether mild head injuries can increase a person"s risk of developing dementia. Epidemiological studies already suggest a link between head injuries and dementia and Dr Fowler will present further work on mice models that has been funded by Alzheimer"s Society. Last month Alzheimer"s Society joined British scientists and other charities to call for a tripling of government investment in dementia research. The charity revealed that despite the success of British researchers the UK government lags behind France, Germany and the US in dementia research funding and has no plans for the future. Professor Clive Ballard, Director of Research at Alzheimer"s Society, says, "It"s fantastic to see so many dementia researchers flying the flag for British research in Vienna. Dementia research in the UK is desperately underfunded. The government spends eight times less on dementia research than on cancer research but despite this lack of funding Britain continues to make important scientific discoveries. Just imagine what we could achieve if we tripled the funding for dementia research and developed a comprehensive plan. In the next ten years a million people will develop dementia; with the right investment dementia can be defeated. Alzheimer"s Society currently invests over ÷£6 million in cutting-edge health and social research, selected by leading experts, people with dementia and carers and is pleased to be showcasing this work at ICAD." Notes - International Conference of Alzheimer"s Disease (ICAD) is organised by Alzheimer"s Association. For more information visit http://www.alz.org/icad - One in three of us over 65 will die with dementia - 700,000 people in the UK have a form of dementia, more than half have Alzheimer"s disease. In less than 20 years nearly a million people will be living with dementia. This will soar to 1.7 million people by 2051 - Alzheimer"s Society champions the rights of people living with dementia and those who care for them. Alzheimer"s Society works in England, Wales and Northern Ireland - Alzheimer"s Society needs to raise money to support people today and to find a cure for tomorrow. You can donate now by calling 0845 306 0898 or visiting http://www.alzheimers.org.uk Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):